We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
+$5.24M
Cap. Flow
-$1.34M
Cap. Flow %
-1.02%
Top 10 Hldgs %
40.79%
Holding
134
New
1
Increased
68
Reduced
50
Closed
4

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$288K
2
WAT icon
Waters Corp
WAT
+$275K
3
CVS icon
CVS Health
CVS
+$245K
4
INDB icon
Independent Bank
INDB
+$243K
5
WFC icon
Wells Fargo
WFC
+$211K

Sector Composition

Rank Sector Weight
1 Technology 16.26%
2 Financials 13.99%
3 Healthcare 4.95%
4 Communication Services 3.49%
5 Consumer Discretionary 2.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOW icon
126
Dow Inc
DOW
$21.9B
$206K 0.16%
+3,765
New +$212K
XLU icon
127
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
$205K 0.16%
6,054
+18
+0.3% +$610
MC icon
128
Moelis & Co
MC
$4.97B
$202K 0.15%
5,248
-190
-3% -$8.16K
AGNC icon
129
AGNC Investment
AGNC
$12.4B
$172K 0.13%
17,111
+4,903
+40% +$53.3K
AGEN
130
Agenus
AGEN
$312M
$30K 0.02%
1,019
CVS icon
131
CVS Health
CVS
$133B
-2,624
Closed -$245K
INDB icon
132
Independent Bank
INDB
$3.99B
-2,882
Closed -$243K
LLY icon
133
Eli Lilly
LLY
$1.02T
-787
Closed -$288K
WFC icon
134
Wells Fargo
WFC
$261B
-5,100
Closed -$211K

Similar funds

O'Rourke & Company's Q1 2023 Portfolio in Review

As of Q1 2023, O'Rourke & Company held 134 positions worth $131M, up 4.2% from $126M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 3.7%. O'Rourke & Company opened 1 new position and exited 4, leaving the 134-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • O'Rourke & Company's largest Q1 2023 buy was Dow Inc: 3,765 shares worth $206K.
  • O'Rourke & Company added most to Analog Devices in Q1 2023, an estimated $268K increase.
  • O'Rourke & Company's biggest Q1 2023 reduction was Waters Corp, cutting an estimated $275K.
  • O'Rourke & Company fully exited Eli Lilly in Q1 2023, selling an estimated $288K.
  • O'Rourke & Company's ten largest holdings make up 41% of its $131M portfolio in Q1 2023.
  • O'Rourke & Company opened 1 new position and closed 4 in Q1 2023.
  • O'Rourke & Company's portfolio value rose 4.2% quarter-over-quarter to $131M.

Based on O'Rourke & Company's 13F filing for Q1 2023, filed 12 May 2023.